Investment Management of Virginia LLC acquired a new stake in Allergan PLC. (NYSE:AGN) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 834 shares of the company’s stock, valued at approximately $203,000.

A number of other large investors have also recently made changes to their positions in the stock. Enterprise Financial Services Corp boosted its position in Allergan PLC. by 62.7% in the first quarter. Enterprise Financial Services Corp now owns 462 shares of the company’s stock valued at $110,000 after buying an additional 178 shares in the last quarter. Jacobi Capital Management LLC boosted its position in Allergan PLC. by 4.9% in the first quarter. Jacobi Capital Management LLC now owns 472 shares of the company’s stock valued at $112,000 after buying an additional 22 shares in the last quarter. JNBA Financial Advisors boosted its position in Allergan PLC. by 2.5% in the first quarter. JNBA Financial Advisors now owns 487 shares of the company’s stock valued at $116,000 after buying an additional 12 shares in the last quarter. Webster Bank N. A. boosted its position in Allergan PLC. by 31.0% in the first quarter. Webster Bank N. A. now owns 520 shares of the company’s stock valued at $124,000 after buying an additional 123 shares in the last quarter. Finally, Pacific Center for Financial Services boosted its position in Allergan PLC. by 805.1% in the first quarter. Pacific Center for Financial Services now owns 534 shares of the company’s stock valued at $128,000 after buying an additional 475 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Shares of Allergan PLC. (AGN) opened at 233.55 on Friday. The firm has a 50-day moving average of $235.62 and a 200 day moving average of $237.29. The company has a market capitalization of $78.08 billion, a P/E ratio of 7.12 and a beta of 1.18. Allergan PLC. has a 1-year low of $184.50 and a 1-year high of $256.80.

Allergan PLC. (NYSE:AGN) last posted its earnings results on Thursday, August 3rd. The company reported $4.02 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.95 by $0.07. Allergan PLC. had a net margin of 79.17% and a return on equity of 7.37%. The firm had revenue of $4.01 billion during the quarter, compared to analysts’ expectations of $3.95 billion. During the same period last year, the company posted $3.35 EPS. The company’s quarterly revenue was up 8.8% compared to the same quarter last year. On average, equities research analysts expect that Allergan PLC. will post $16.27 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, September 15th. Stockholders of record on Friday, August 18th will be given a $0.70 dividend. The ex-dividend date of this dividend is Wednesday, August 16th. This represents a $2.80 annualized dividend and a dividend yield of 1.20%. Allergan PLC.’s dividend payout ratio is 9.95%.

A number of analysts have weighed in on the stock. Royal Bank Of Canada restated a “buy” rating and issued a $285.00 target price on shares of Allergan PLC. in a research report on Wednesday. Cantor Fitzgerald reiterated a “hold” rating on shares of Allergan PLC. in a report on Tuesday, August 29th. Cowen and Company reiterated an “outperform” rating and set a $400.00 price target on shares of Allergan PLC. in a report on Tuesday, August 29th. BidaskClub lowered shares of Allergan PLC. from a “sell” rating to a “strong sell” rating in a report on Friday, August 25th. Finally, Argus reiterated a “buy” rating and set a $280.00 price target on shares of Allergan PLC. in a report on Monday, August 14th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and fifteen have issued a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $275.49.

TRADEMARK VIOLATION NOTICE: “Investment Management of Virginia LLC Acquires Shares of 834 Allergan PLC. (AGN)” was originally published by Daily Political and is the property of of Daily Political. If you are viewing this report on another site, it was stolen and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://www.dailypolitical.com/2017/09/10/investment-management-of-virginia-llc-acquires-shares-of-834-allergan-plc-agn.html.

Allergan PLC. Profile

Allergan, Inc is a multi-specialty healthcare company. The Company focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter (OTC) products. It discovers, develops and commercializes a range of products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets.

Institutional Ownership by Quarter for Allergan PLC. (NYSE:AGN)

Receive News & Ratings for Allergan PLC. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergan PLC. and related companies with MarketBeat.com's FREE daily email newsletter.